MENU
REPL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Replimune Group (REPL) Earnings Date & Reports
Replimune Group Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
REPL is expected to report earnings to fall 16.87% to -63 cents per share on July 30
Q2'26
Est.
$-0.63
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.11
The last earnings report on June 29 showed earnings per share of -75 cents, missing the estimate of -68 cents. With 514.36K shares outstanding, the current market capitalization sits at 927.59M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of oncolytic immunotherapies
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
479
Web
https://www.replimune.com